Schonfeld Strategic Advisors LLC Aligos Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.04 - $2.14 $27,560 - $56,710	-26,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.08 - $12.2 $55,120 - $323,300	26,500 New	26,500 $57,000
Q1 2021 May 17, 2021	SELL	$19.1 - $34.94 $566,830 - $1.04 Million	-29,677 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.2 - $32.74 $391,736 - $971,624	29,677 New	29,677 $821,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.